Sinclair Pharmaceuticals, a small drug company, hasdeveloped a vaccine that will protect againstHelicobacter pylori, a bacterium that is the cause of anumber of diseases of the stomach. It is expected thatSinclair Pharmaceuticals will experience extremely highgrowth over the next three years & will reinvest all of itsearnings in expanding the company over this time.Earnings were $1.65 per share before the development ofthe vaccine (in year 0) & are expected to grow by 40%per year for the next three years. After this time, it isexpected that growth will drop to 6% & stay there for theexpected future. Four years from now Sinclair will beginpaying dividends that are equal to 75% of its earnings. Ifits equity cost of capital is 12%, what is the value of ashare of Sinclair Pharmaceuticals today?

1. **Earnings Growth Projection**: - The problem states that earnings per share (EPS) were $1.65…

Answered: Sinclair Pharmaceuticals, a small drug…

Essentials Of Investments

11th Edition

ISBN:9781260013924

Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.

Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.

Chapter1: Investments: Background And Issues

Section: Chapter Questions

Problem 1PS

See similar textbooks

Similar questions

Following the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical companyis considering introducing a new vaccine unto the market to help fight the virus. This will requirethe injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment forproduction. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility andinstall that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine couldbe manufactured in a building owned by the firm and located in East Legon. This vacant buildingand the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the
AD, a pharmaceutical company, has developed a new drug that will supposedly cure COVID-19 and provide immunity to the general population. The results are so promising that the company will purchase land for $1M to build a manufacturing center that will produce this drug in sufficient quantities. This facility will cost $185 million to build. The project will take 10 years and will initially require $535 million in net working capital. Also, the company will spend $5 million on R&D and $4 million in marketing the drug to the general population. The drug will sell for $1,500 in the first five years. Anticipating improved efficiency the drug will sell for $1,250 in years 6 through 9 and $1,000 in year 10. Variable costs will be $400 per unit. Annual fixed costs will be 11% of that year’s total revenue. Marketing has projected annual sales as follows: PROJECT YEAR ANNUAL UNIT SALES 1 15,000 2 25,000 3 100,000 4 100,000 5 100,000 6…
Merck and Johnson & Johnson Merck & Co., Inc. (USA) and Johnson & Johnson (USA)are two leading producers of healthcare products. Each has considerable assets and each expendsconsiderable funds each year toward the development of new products. The development of anew healthcare product is often very expensive and risky. New products frequently must undergoconsiderable testing before approval for distribution to the public. For example, it took Johnson& Johnson 4 years and $200 million to develop its 1-DAY ACUVUE contact lenses. Thefollowing are some basic data compiled from the financial statements of these two companies. Instructions(a) What kinds of intangible assets might a healthcare products company have? Does thecomposition of these intangibles matter to investors—that is, would it be perceived differently ifall of Merck’s intangibles were goodwill, than if all of its intangibles were patents?(b) Suppose the president of Merck has come to you for…
Khair Ltd carries out research and development on a continuousbasis. The directors of the company are passionate aboutimproving their medicinal drugs and finding new cures.In the current financial year, the company has been makingsignificant findings regarding a vaccine for the coronavirus. To thiseffect, they have registered a patent for a new vaccine that willsoon be available to customers. The following costs have beenincurred in respect of the patent in the current financial year.Research salaries R250 000Development salaries R450 000Initial marketing costs R30 000Fees to register patent R78 000Materials used in development R12 000The development was completed on 1 July 2020.Patents are amortised on a straight‐line basis at 20% per annumwith no residual value.Prepare the journal entry to recognise the patent in the financialstatements of Khair Ltd on 1 July 2020.Narrations are required
Following the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical company is considering introducing a new vaccine unto the market to help fight the virus. This will require the injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment for production. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility and install that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine could be manufactured in a building owned by the firm and located in East Legon. This vacant building and the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the vaccine (including initial working capitalinvestment) by issuing 2000,000 new common stocks at GH¢ 20 per share from its existing shareholders. A total of GH¢ 15,000,000 is expected to be raised from the rights issue. It expects to finance the remaining from the issue of a 5-year bondwith a before-tax yield to…
Following the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical company is considering introducing a new vaccine unto the market to help fight the virus. This will require the injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment for production. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility and install that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine could be manufactured in a building owned by the firm and located in East Legon. This vacant building and the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the vaccine (including initial working capital investment) by issuing 2000,000 new common stocks at GH¢ 20 per share from its existing shareholders. A total of GH¢ 15,000,000 is expected to be raised from the rights issue. It expects to finance the remaining from the issue of a 5-year bond with a before-tax yield to maturity (YTM)…
Following the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical company is considering introducing a new vaccine unto the market to help fight the virus. This will require the injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment for production. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility and install that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine could be manufactured in a building owned by the firm and located in East Legon. This vacant building and the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the vaccine (including initial working capital investment) by issuing 2000,000 new common stocks at GH¢ 20 per share from its existing shareholders. A total of GH¢ 15,000,000 is expected to be raised from the rights issue. It expects to finance the remaining from the issue of a 5-year bond with a before-tax yield to maturity (YTM)…
Following the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical company is considering introducing a new vaccine unto the market to help fight the virus. This will require the injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment for production. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility and install that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine could be manufactured in a building owned by the firm and located in East Legon. This vacant building and the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the vaccine (including initial working capital investment) by issuing 2000,000 new common stocks at GH¢ 20 per share from its existing shareholders. A total of GH¢ 40,000,000 is expected to be raised from the rights issue. It expects to finance the remaining investment including initial working capital investment from the issue of a…
Parasite Engineering is developing a new product for the parasitic market that services parasites. The opportunity is estimated to be worth $1.0B measured in today’s dollars. The company will need to spend $500M today to begin the research. In five years, the company will have to make a decision as to whether to go into full scale production and begin selling the drug. At that time, the company estimates it will cost $1.5B to move forward. If the appropriate risk-free rate is 2.5%, how high must the annual volatility be to make the project worth beginning?
Harrison Jones is a marketer of facial care products. It plans on introducing a new product line next year and is not quite certain whether its sales team can accomplish the sales objectives. It must determine how much dollar business it must do to at least break even. Its historical average annual sales has been $10,000,000 and its cost of sales has been $4,500,000. Its planned investment in the new business is $450,000. How much dollar business must Harrison Jones do in order to recoup its planned investment?
Due to the ongoing COVID 19 Pandemic, Sterilic Ltd had decided to expand their sanitation product line to include the production of disposable face masks. The equipment will cost Sterilic $1,575,000 and it will cost $425,000 to install. Sterilic believes there will be a steady demand of masks at least for next five years and so it expects this project will generate after-tax cash flows of $654,500 per year for the 5 year life of the project, with the first cash flow starting at the end of first year. Sterilic will raise the fund for the new project by a mix of new debt and new equity that will maintain its target debt to equity ratio of 0.25. Sterilic wishes to raise the funds by: A new issue of ordinary shares. The floatation costs of the new share issue would be 10% of the amount raised. The beta for Sterilic is 1.75, the risk free rate is 2.5% and the market rate of return is 9.5%. A new issue of 5-year Bonds with yield to maturity of 6.25% pa. The floatation costs of the new…
Harriet Moore is an accountant for New World Pharmaceuticals. Her duties include tracking research and development spending in the new product development division. Over the course of the past six months, Harriet has noticed that a great deal of funds have been spent on a particular project for a new drug. She hears “through the grapevine” that the company is about to patent the drug and expects it to be a major advance in antibiotics. Harriet believes that this new drug will greatly improve company performance and will cause the company’s stock to increase in value. Harriet decides to purchase shares of New World in order to benefit from this expected increase. Required What are Harriet’s ethical responsibilities, if any, with respect to the information she has learned through her duties as an accountant for New World Pharmaceuticals? What are the implications of her planned purchase of New World shares?

SEE MORE QUESTIONS

Recommended textbooks for you

Essentials Of Investments

Finance

ISBN:

9781260013924

Author:

Bodie, Zvi, Kane, Alex, MARCUS, Alan J.

Publisher:

Mcgraw-hill Education,

FUNDAMENTALS OF CORPORATE FINANCE

Finance

ISBN:

9781260013962

Author:

BREALEY

Publisher:

RENT MCG

Financial Management: Theory & Practice

Finance

ISBN:

9781337909730

Author:

Brigham

Publisher:

Cengage

Essentials Of Investments

Finance

ISBN:

9781260013924

Author:

Bodie, Zvi, Kane, Alex, MARCUS, Alan J.

Publisher:

Mcgraw-hill Education,

FUNDAMENTALS OF CORPORATE FINANCE

Finance

ISBN:

9781260013962

Author:

BREALEY

Publisher:

RENT MCG

Financial Management: Theory & Practice

Finance

ISBN:

9781337909730

Author:

Brigham

Publisher:

Cengage

Foundations Of Finance

Finance

ISBN:

9780134897264

Author:

KEOWN, Arthur J., Martin, John D., PETTY, J. William

Publisher:

Pearson,

Fundamentals of Financial Management (MindTap Cou…

Finance

ISBN:

9781337395250

Author:

Eugene F. Brigham, Joel F. Houston

Publisher:

Cengage Learning

Corporate Finance (The Mcgraw-hill/Irwin Series i…

Finance

ISBN:

9780077861759

Author:

Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor

Publisher:

McGraw-Hill Education

SEE MORE TEXTBOOKS